Τόμος 12 (1994) – Τεύχος 3 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 12 (1994) – Issue 3 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Ν.Γ. Οικονομάκος¹, Μ. Κοντού¹, Σ.Ε. Ζωγράφος¹, Δ.Δ. Κουτρά¹, L.N. Johnson², K.A. Watson², E.P. Mitchell², G.W.J. Fleet³, J.C. Son³ και C.J.F. Bichard³

¹ Ινστιτούτο Βιολογικών Ερευνών και Βιοτεχνολογίας, Εθνικό Ιδρυμα Ερευνών, Βασ. Κωνσταντίνου 48, Αθήνα 11635, Ελλάδα ² Laboratory of Molecular Biophysics, University of Oxford, South Parks Road, Oxford OX1 3QU, ³ Dyson Perrins Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QY, UK

N.G. Oikonomakos¹, Μ. Kontou¹, S.E. Zographos¹, D.D. Koutra¹, L.N. Johnson², K.A. Watson², E.P. Mitchell², G.W.J. Fleet³, J.C. Son³ and C.J.F. Bichard³

¹ Institute of Biological Research & Biotechnol­ogy, The National Hellenic Research Foundation, 48 Vas. Constantinou Ave, Athens 11635, Greece, ² Laboratory of Molecular Biophysics, University of Oxford, South Parks Road, Oxford OX1 3QU, ³ Dyson Perrins Laboratory, University of Ox­ford, South Parks Road, Oxford OX1 3QY, UK

1. Beddell, C.R., Goodford, P.J., Kneen, G., White, R.D., Wilkinson, S., Wootton, R.: Substituted ben­zaldehydes designed to increase the oxygen-affinity of human-hemoglobin and inhibit the sickling of sickle erythrocytes. Br. J. Pharmacol. 82, 397-407 (1984)
2. Edsall, J.T., McKenzie, H.A.: Water and pro­teins. 2. The location and dynamics of water in protein systems and its relation to their stability and proper­ties. Adv. Biophys. 16, 53-183 (1983)
3. Appelt, K., Bacquet, R.J., Bartlett, C.A., Booth, C.L.J., Freer, S.T., Fuhry, M.A.M., Gehring, M.R., Herrmann, S.M., Howland, E.F., Janson, C.A., Jones, T.R., Kan, C.-C., Kathardekar, V., Lewis, K.K., Marzoni, G.P., Matthews, D.A., Mohr, C., Moomaw, E.W., Morse, C.A., Oatley, S.J., Ogden, R.C., Reddy, M.R., Reich, S.H., Schoettlin, W.S., Smith, W.W., Varney, M.D., Villafranca, J.E., Ward, R.W., Webber, S., Webber, S.E., Welsh, K.M., White, J.: Design of enzyme inhibitors using iterative protein crystallographic analysis. J. Med. Chem. 34, 1925-1934 (1991)
4. Shoichet, B.K., Stroud, R.M., Santi, D.V., Kuntz, I.D., Perry, K.M.: Structure-based discovery of in­hibitors of thimidylate synthase. Science 259, 1445-1450 (1993)
5. Ealick, S.E., Babu, Y.S., Bugg, C.E., Erion, M.D., Guida, W.C., Montgomery, J.A., Secrist, J.A. III: Application of crystallographic and modeling methods in the design of purine nucleoside phos­phorylase inhibitors. Proc. Natl. Acad. Sci. USA 88, 11540-11544 (1991)
6. Baldwin, J.J., Ponticello, G.S., Anderson, P.S., Christy, M.E., Murcko, M.A., Randall, W.C., Sch­wam, H., Surgue, M.F., Springer, J.P., Gautheron, P., Grove, J., Mallorga, P., Viader, M.-P., McKeever, B.M., Navia, M.A.: Thienothiopyran-2-sulfonamides: Novel topically active carbonic anhy­drase inhibitors for the treatment of glaucoma. J. Med. Chem. 32, 2510-2513 (1989)
7. Abdel-Meguid, S.S., Zhao, B., Murthy, K.H.M., Winborne, E., Choi, J.-K., DesJarlais, R.L., Minnich, M.D., Culp, J.S., Debouck, C., Tomaszek, T.A., Jr., Meek, T.D., Dreyer, G.B.: Inhibition of human im­munodeficiency virus-1 protease by a C2-Symmetric phosphinate. Synthesis and crystallographic analy­sis. Biochemistry 32, 7972-7980 (1993)
8. von Itzstein, M., Wu, W.-Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Phan, T.V., Smythe, M.L., White, H.F., Oliver, S.W., Colman, P.M., Varghese, J.N., Ryan, D.M, Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R.: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423 (1993)
9. Chapman, M.S., Minor, I., Rossmann, M.G., Di­ana, G.D., Andries, K.: Human rhinovirus 14 com­plexed with antiviral compound R 61837. J. Mol. Biol. 217, 455-463 (1991)
10. Kim, K.H., Willingmann, P., Gong, Z.X., Kremer, M.J., Chapman, M.S., Minor, I., Oliveira, M.A., Rossmann, M.G., Andries, K., Diana, G.D., Dutko, F.J., McKinlay, M.A., Pevear, D.C.: A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J. Mol. Biol. 230, 206-227 (1993)
11. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A., Steitz, T.A.: Crystal structure at 3.5 resolu­tion of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790 (1992)
12. Jacobo-Molina, A., Ding, J., Nanni, R.G., Clark, A.D., Jr., Lu, X., Tantillo, C., Williams, R.L., Kamer, G., Ferris, A.L., Clark, P., Hizi, A., Hughes, S.H., Arnold, E.: Crystal structure of human immunodefi­ciency virus 1 reverse transcriptase complexed with double-stranded DNA at 3.0 resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90, 6320-6324 (1993)
13. Blundell, T., Hubbard, R., Weiss, M.A.: Struc­tural biology and diabetes mellitus: molecular patho­genesis and rational drug design. Diabetologia 35 [Suppl 2], S69-S76 (1992)
14. Perutz, M.: Protein Structure. New Approaches to Disease and Therapy, W.H. Freeman and Com­pany, New York, 1992
15. Papageorgiou, A.C., Oikonomakos, N.G., Leoni­das, D.D.: Design of potential drugs through protein crystallography. Review of Clinical Pharmacology and Pharmacokinetics, International Edition (Plessas, S.T. & Plessas, C.T., eds), Vol. 7, pp. 27-47, Pub­lished by Pharmakon Press, Athens, Greece, 1993
16.  Goodfellow, P.N., Schmitt, K.: From the simple to the complex: a brief history of diabetes. Nature 371, 104-105 (1994)
17. DeFronzo, R.A.: The triumvirate beta-cell, mus­cle, liver. A collusion responsible for NIDDM. Diabe­tes 37, 667-687 (1988)
18. Barford, D., Johnson, L.N.: The allosteric transi­tion of glycogen phosphorylase. Nature 340, 609-616 (1989)
19. Barford, D., Hu, S.-H., Johnson, L.N.: Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP. J. Mol. Biol. 218, 233-260 (1991)
20. Monod, J., Wyman, J., Changeux, J.-P.: On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12, 88-118 (1965)
21. Johnson, L.N.: Glycogen phosphorylase: control by phosphorylation and allosteric effectors. FASEB J. 6, 2274-2282 (1992)
22. Oikonomakos, N.G., Acharya, K.R., Johnson, L.N.: Rabbit muscle glycogen phosphorylase b : structural basis of activation and catalysis. in Post-Translational Modification of Proteins (Harding, J.J. and Crabbe, M.J.C., eds.), pp. 81-151, CRC Press, Boca Raton, FL, 1992
23. Johnson, L.N., Hajdu, J., Acharya, K.R., Stuart, D.I., McLaughlin, P.J., Oikonomakos, N.G., Barford, D.: Glycogen phosphorylase. In: Allosteric Enzymes (Herve, G., ed.), pp. 81-127, CRC Press, Boca Ra­ton, FL, 1989
24. Newgard, C.B., Hwang, P.K., Fletterick, R.J.: The family of glycogen phosphorylases: structure and function. Crit. Rev. Biochem. Mol. Biol. 24, 69-99 (1989)
25. Dent, P., Lavoine, A., Nakielny, S., Caudwell, F.B., Watt, P., Cohen, P.: The molecular mecha­nism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348, 302-308 (1990)
26. Cohen, P.: Signal integration of the level of pro­tein kinases, protein phosphatases and their sub­strates. Trends Biochem. Sci. 17, 408-413 (1992)
27. Stalmans, W., De Wulf, H., Hue, L., Hers, H.G.: The interaction of liver phosphorylase a with glu­cose. Eur. J. Biochem. 41, 127-134 (1974)
28. Hers, H.G.: The control of glycogen metabolism in the liver. Annu. Rev. Biochem. 45, 167-189 (1976)
29. Witters, L.A., Avruch, J.: Insulin regulation of hepatic glycogen synthase and phosphorylase. Bio­chemistry 17, 406-410 (1978)
30. Hartmann, H., Probst, I., Jungermann, K., Creutzfeldt, W.: Inhibition of glycogenolysis and gly­cogen phosphorylase by insulin and proinsulin in rat hepatocyte cultures. Diabetes 36, 551-555 (1987)
31. Martin, J.L., Veluraja, K., Ross, K., Johnson, L.N., Fleet, G.W.J., Ramsden, N.G., Bruce, I., Or­chard, M.G., Oikonomakos, N.G., Papageorgiou, A.C., Leonidas, D.D., Tsitoura, H.S.: Glucose ana­logue inhibitors of glycogen phosphorylase: The de­sign of potential drugs for diabetes. Biochemistry 30, 10101-10116 (1991)
32. Papageorgiou, A.C., Oikonomakos, N.G., Leoni­das, D.D., Bernet, B., beer, D., Vasella, A.: The binding of D-gluconohydroximo-1,5-lactone to glyco­gen phosphorylase: kinetic, ultracentrifugation and crystallographic studies. Biochem. J. 274, 329-338 (1991)
33. Oikonomakos, N.G., Kontou, M., Zographos, S.E., Tsitoura, H.S., Johnson, L.N., Watson, K.A., Mitchell, E.P., Fleet, G.W.J., Son, J.C., Bichard, C.J.F., Leonidas, D.D., Acharya, K.R. (1994). The design of potential antidiabetic drugs: experimental investigation of a number of β–D-glucose analogue inhibitors of glycogen phosphorylase. Eur. J. Drug Metabol. Pharmacokin., 185-192 (1994)
34. Madsen, N.B., Kasvinsky, P.J., Fletterick, R.J.: Allosteric transitions of phosphorylase a and the regulation of glycogen metabolism. J. Biol. Chem. 253, 9097-9101 (1978)
35. Kasvinsky, P.J., Fletterick, R.J., Madsen, N.B.: Regulation of the dephosphorylation of glycogen phosphorylase a and glycogen synthase b by glu­cose and caffeine in isolated hepatocytes. Can. J. Biochem. 59, 387-395 (1981)
36. Sprang, S.R., Goldsmith, E.J., Fletterick, R.J., Withers, S.G., Madsen, N.B.: Catalytic site of glyco­gen phosphorylase: structure of the T state and specificity for α–D-glucose. Biochemistry 21, 5364-5371 (1982)
37. Bollen, M., Stalmans, W.: The structure, role, and regulation of type-1 protein phosphatases. Crit. Rev. Biochem. Mol. Biol. 27, 227-281 (1992)
38. Alemany, S., Cohen, P.: Phosphorylase a is an allosteric inhibitor of the glycogen and microsomal forms of rat hepatic protein phosphatase-1. FEBS Lett. 198, 194-202 (1986)
39. Acharya, K.R., Stuart, D.I., Varvil, K.M., John­son, L.N.: Glycogen Phosphorylase b: Description of the Protein Structure, pp. 1-123. World Scientific Pub­lishing Co. Pte. Ltd., Singapore, 1991
40. Martin, J.L., Johnson, L.N., Withers, S.G.: Com­parison of the binding of glucose and glucose-1-phosphate derivatives to T state glycogen phos­phorylase b. Biochemistry 29, 10745-10757 (1990)
41. Watson, K.A., Mitchell, E.P., Johnson, L.N., Son, J.C., Bichard, C.J.F., Fleet, G.W.J., Ford, P., Wat­kin, D.J., Oikonomakos, N.G.: X-ray crystal­lographic analysis of 2,6-anhydro-N-methyl-D-glyc­ero-D-iso-heptonamide: the first example of a simple glucose analogue with a skew boat structure. J. Chem. Soc., Chem. Commun. 7, 654-656 (1993)
42. Watson, K.A., Mitchell, E.P., Johnson, L.N., Son, J.C., Bichard, C.J.F., Orchard, M.G., Fleet, G.W.J., Oikonomakos, N.G., Leonidas, D.D., Kon­tou, M., Papageorgiou, A.C.: The design of inhibi­tors of gly­cogen phosphorylase: a study of α and β glucohep­tonamides and 1-thio-β–D-glucose com­pounds. Bio­chemistry 33, 5745-5758 (1994)
43. Oikonomakos, N.G., Acharya, K.R., Stuart, D.I., Melpidou, A.E., McLaughlin, P.J., Johnson, L.N.: Uridine(5′)diphospho(1)-α–D-glucose. A binding study to glycogen phosphorylase b in the crystal. Eur. J. Biochem. 173, 569-578 (1988)
44. Goldsmith, E.J., Sprang, S.R., Hamlin, R., Xuong, N.-H., Fletterick, R.J.: Domain separation in the activation site of glycogen phosphorylase a. Sci­ence 245, 528-532 (1989)
45. Quiocho, F.A.: Protein-carbohydrate interac­tions: basic molecular-features. Pure & Appl. Chem. 61, 1293-1306 (1989)
46. Quiocho, F.A.: Carbohydrate binding proteins: tertiary structures and protein-sugar interactions. Ann. Rev. Biochem. 55, 287-315 (1986)
47. Vyas, N.K., Meenakshi, N.V., Quiochio, F.A.: Sugar and signal-transducer binding sites of the E. coli galactose chemoreceptor protein. Science 242, 1290-1295 (1988)
48. Hol, W.G.: Protein crystallography and computer graphics-toward rational drug design. Angew. Chem. Int. Ed. Engl. 25, 767-778 (1986)
49. Barford, D., Schwabe, J.W.R., Oikonomakos, N.G., Acharya, K.R., Hajdu, J., Papageorgiou, A.C., Martin, J.L., Knott, J.C.A., Vasella, A., Johnson, L.N.: Channels at the catalytic site of glycogen phosphorylase b : binding and kinetic studies with the β–glycosidase inhibitor, D-gluconohydroximo-1,5-lac­tone-N-phenylurethane. Biochemistry 27, 6733-6641 (1988)
50. Johnson, L.N., Watson, K.A., Mitchell, E.P., Fleet, G.W.J., Son, J.C., Bichard, C.J.F., Oikonomakos, N.G., Papageorgiou, A.C., Leonidas, D.D.: Glucose analog inhibitors of glycogen phos­phorylase. In: Complex Carbohydrates in Drug Re­searh, Alfred Benzon Symposium 36 (K. Bock & H. Clausen, Eds.), pp. 214-226, Copenhagen, 1994
51. Cori, G.T., Cori, C.F.: The kinetics of the en­zymic synthesis of glycogen from glucose-1-phos­phate. J. Biol. Chem. 135, 733-756 (1940)
52. Ariki, M., Fukui, T.: Affinity of glucose analogs for α–glucan phosphorylases from rabbit muscle and potato tubers. J. Biochem. (Tokyo) 81, 1017-1024 (1977)
53. Street, I.P., Armstrong, C.R., Withers, S.G.: Hy­drogen bonding and specificity. Fluorodeoxy sug­ars as probes of hydrogen bonding in the glycogen phosphorylase-glucose complex. Biochemistry 25, 6021-6027 (1986)
54. Segel, I.H.: Enzyme Kinetics, pp. 465-504, Wiley-Interscience, New York, 1975
55. Fischer, E.H., Krebs, E.G.: Muscle phosphory­lase b. In: Methods of Enzymology. (Colowick, S.P. and Kaplan, N.O., eds.), Vol. 5, 369-373, Academic Press, San Diego, 1962
56. Helmreich, E., Cori, C.F.: The role of adenylic acid in the activation of phosphorylase. Proc. Natl. Acad. Sci. U,S.A. 51, 131-138 (1964)
57. Melpidou, A.E., Oikonomakos, N.G.: Effects of glucose-6-P on the catalytic and structural proper­ties of glycogen phosphorylase a. FEBS Lett. 154, 105-110 (1983)
58. Kastenschmidt, L.L., Kastenschmidt, J., Helm­reich, E.: The effect of temperature on the allosteric transition of glycogen phosphorylase b. Biochemistry 7, 3590-3608 (1968)
59. Leonidas, D.D., Oikonomakos, N.G., Papageor­giou, A.C., Sotiroudis, T.G.: Kinetic properties of tetrameric glycogen phosphorylase b in solution and in the crystalline state. Protein Sci. 1, 1123-1132 (1992)
60. Leatherbarrow, R.J.: GraFit Version 3.0, Erithakus Software, Staines, UK, 1992
61. Leatherbarrow, R.J.: Using linear and non-linear regression to fit biochemical data. Trends Biochem. Sci. 15, 455-458 (1990)
62. Madsen, N.B., Shechosky, S.: Allosteric proper­ties of phosphorylase b. II. Comparison with a ki­netic model. J. Biol. Chem. 242, 3301-3307 (1967)
63. Helmreich, E., Michaelides, M.C., Cori, C.F.: Ef­fect of substrates and substrate analogs on the binding of 5′-adenylic acid to muscle phosphorylase a. Biochemistry 6, 3695-3710 (1967)
64. Perutz, M.: Mechanisms of cooperativity and allosteric regulation in proteins. Q. Rev. Biophys. 22, 139-237 (1989)
65. Oikonomakos, N.G., Melpidou, A.E., Johnson, L.N.: Crystallization of pig skeletal phosphorylase b. Purification, physical and catalytic characterization. Biochim. Biophys. Acta 832, 248-256 (1985)
66. Howard, A.J., Gilliland, G.L., Finzel, B.C., Pou­los, T.L., Ohlendorf, D.H., Salemme, F.R.: The use of an imaging proportional counter in macromolecu­lar crystallography. J. Appl. Crystallogr. 20, 383-387 (1987)
67. Kabsch, W.J.: Automatic-indexing of rotation diffraction patterns. J. Appl. Crystallogr. 21, 67-71 (1988)
68. Kabsch, W.J.: Evaluation of single crystal X-ray diffraction data for a position sensitive detector. J. Appl. Crystallogr. 21, 916-924 (1988)
69. Brunger, A.T.: Crystallographic refinement by simulated annealing. Application to a 2.8 resolu­tion structure of aspartate aminotransferase. J. Mol. Biol. 203, 803-816 (1988)
70. Brunger, A.T.: A memory-efficient fast Fourier crystallographic refinement on supercomputers. Acta Crystallogr. Sect. A45, 42-50 (1989)
71. Brunger, A.T., Karplus, M., Petsko, G.A.: Crys­tallographic refinement by simulated annealing: ap­plication to crambin. Acta Crystallogr. Sect. A45, 50-61 (1989)
72. Jones, T.A.: A graphics model building and re­finement system for macromolecules. J. Appl. Crys­tallogr. 11, 268-272 (1978)
73. Jones, T.A.: Interactive computer graphics: FRODO. Methods Enzymol. 115, 157-171 (1985)
74. Jeffrey, G.A., Saenger, W.: Hydrogen Bonding in Biological Structures, p. 29, Springer-Verlag, Ber­lin, Heidelberg, New York, 1994
75. Burley, S.K. Petsko, G.A.: Weakly polar interac­tions in proteins. In: Advances in Protein Chemistry 39, 125-189, Academic Press Inc, 1988